EP PerMed - the European Partnership for Personalised Medicine’s Post

𝘕𝘦𝘸 𝘌𝘗 𝘗𝘦𝘳𝘔𝘦𝘥 𝘊𝘢𝘭𝘭: RITC2026 - 𝐓𝐞𝐬𝐭 𝐚𝐧𝐝 𝐃𝐞𝐦𝐨𝐧𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐌𝐮𝐥𝐭𝐢𝐦𝐨𝐝𝐚𝐥 𝐃𝐚𝐭𝐚 𝐀𝐩𝐩𝐫𝐨𝐚𝐜𝐡𝐞𝐬 𝐟𝐨𝐫 𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐬𝐞𝐝 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 (#MultiPMData2026) EP PerMed launched its first research, innovation and technology call (RITC2026) for proposals on “Test and Demonstration of Multimodal Data Approaches for #PersonalisedMedicine” on 1 October 2025. In total, 19 funding organisations participate in this call with an available budget of approx.14.8 Mio. €. EP PerMed will fund innovation projects in human health that focus on multimodal data usage for personalised medicine approaches providing more efficient and personalised management of patients with multimorbidity, having at least two chronic diseases that require management. The call aims to bring together enterprises with clinical actors, including healthcare providers, patients, and researchers, to test innovative solutions in controlled real-world settings to address clear needs in managing multimorbidity. 📆 𝐓𝐢𝐦𝐞𝐥𝐢𝐧𝐞: 1 October 2025 - 𝘗𝘶𝘣𝘭𝘪𝘤𝘢𝘵𝘪𝘰𝘯 𝘰𝘧 𝘵𝘩𝘦 𝘤𝘢𝘭𝘭 28 October 2025 - 𝘙𝘐𝘛𝘊2026 𝘐𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯 𝘋𝘢𝘺 – 𝘰𝘯𝘭𝘪𝘯𝘦 𝘸𝘦𝘣𝘪𝘯𝘢𝘳 18 November 2025 - 𝘙𝘐𝘛𝘊2026 𝘔𝘢𝘵𝘤𝘩𝘮𝘢𝘬𝘪𝘯𝘨 𝘌𝘷𝘦𝘯𝘵 – 𝘰𝘯𝘭𝘪𝘯𝘦 𝘦𝘷𝘦𝘯𝘵 12 January 2026 (14:00, CET) - 𝘋𝘦𝘢𝘥𝘭𝘪𝘯𝘦 𝘧𝘰𝘳 𝘱𝘳𝘦-𝘱𝘳𝘰𝘱𝘰𝘴𝘢𝘭 𝘴𝘶𝘣𝘮𝘪𝘴𝘴𝘪𝘰𝘯 27 April 2026 (14:00, CEST) - 𝘋𝘦𝘢𝘥𝘭𝘪𝘯𝘦 𝘧𝘰𝘳 𝘧𝘶𝘭𝘭-𝘱𝘳𝘰𝘱𝘰𝘴𝘢𝘭 𝘴𝘶𝘣𝘮𝘪𝘴𝘴𝘪𝘰𝘯 September 2026 - 𝘊𝘰𝘮𝘮𝘶𝘯𝘪𝘤𝘢𝘵𝘪𝘰𝘯 𝘰𝘧 𝘵𝘩𝘦 𝘧𝘶𝘯𝘥𝘪𝘯𝘨 𝘥𝘦𝘤𝘪𝘴𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘢𝘱𝘱𝘭𝘪𝘤𝘢𝘯𝘵 🔗 All information on the RITC2026 is available on the call website: https://lnkd.in/d8fiQuVq

Now officially open! A systems innovation-supporting call for proposals dedicated to the support of managing #multimorbidity through innovative solutions tested in controlled real-world settings. The call in EP PerMed - the European Partnership for Personalised Medicine is funded by 19 organisations plus EU-cofunding, Vinnova will fund the participation of swedish companies (of all sizes), academic actors, clinical actors and private non-profit organisations. #personalisedmedicine #precisionmedicine #chronicdiseases #multimorbidity #healthdata

New funding opportunity! EP PerMed has just launched its Research, Innovation & Technology Call 2026 under the theme “Test & Demonstration of Multimodal Data Approaches for Personalised Medicine” (MultiPMData2026).   With a budget of €14.8 million+, this call supports bold, multi‑stakeholder consortia that aim to translate multimodal health data into real‑world personalised medicine solutions for patients with chronic diseases.   Ready to turn data into impact? Join the future of personalised medicine today.

#AbbottProud to see five years of insights from the UNIVANTS of Healthcare Excellence program published in JALM. Discover how 72 best practices are reshaping healthcare with measurable value. Read the article to learn more “Electric Trends of Laboratory Medicine: Five Years of Growth, Visibility, and Opportunity.” https://lnkd.in/eJ9CXtqK #UNIVANTS

𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐢𝐧𝐠 𝐚 𝐍𝐞𝐰 𝐄𝐫𝐚 𝐨𝐟 𝐄𝐯𝐢𝐝𝐞𝐧𝐜𝐞-𝐁𝐚𝐬𝐞𝐝 𝐏𝐞𝐩𝐭𝐢𝐝𝐞 𝐔𝐬𝐞 As #peptidetherapies rapidly advance, bridging the gap between controlled trials and real-world patient experiences is critical. RegenMed’s innovative Circles platform is designed to collect validated, longitudinal data directly from physicians and patients, enabling safer, more effective treatment protocols and faster innovation. This initiative offers new opportunities for researchers and healthcare providers to contribute to a growing evidence base that shapes the future of #peptidetherapeutics. Specialists interested in collaborating on this cutting-edge work are invited to reach out. Contact us to join the movement: https://lnkd.in/e-djDS7P

🌍 Driving Health Innovation Through International Collaboration On the final day of DOLMED.Tech, Philip Pasler , President of the Management Board at #KCM #Clinic S.A., took part in a panel discussion titled “Collaboration that Heals: Medicine and Science of the Future Without Borders.” 💡 Together with experts, Philip Pasler emphasized the importance of international cooperationin advancing innovation and improving healthcare standards across Europe. Representing KCM Clinic, he highlighted the clinic’s active role in building partnerships that integrate modern technology, research, and patient-centered care. 🏥 KCM Clinic continues to support initiatives that foster global knowledge exchange and help shape the future of personalized medicine. #HealthInnovation #P4Health #InternationalCollaboration #Biobanking #KCMClinic

#AbbottProud to see five years of insights from the UNIVANTS of Healthcare Excellence program published in JALM. Discover how 72 best practices are reshaping healthcare with measurable value. Read the article to learn more “Electric Trends of Laboratory Medicine: Five Years of Growth, Visibility, and Opportunity.” https://lnkd.in/e8462x-e #UNIVANTS

Diagnostics should be seen for what they truly are... a smart investment in better healthcare, not just another expense. When applied effectively, diagnostics help prevent mistreatment, shorten patient pathways, and make the healthcare system more efficient and sustainable. Yet, even though around 70% of all clinical decisions depend on diagnostic results, the field still receives only a small share (about 3–5%) of total healthcare spending. This perspective is gaining international traction and in 2023, WHO adopted its first global resolution on diagnostics, urging all member countries, including Denmark, to integrate diagnostics into their national health strategies. As the newly appointed Chair of Medicoindustrien’s expert group ‘Diagnostik i Sundhedsvæsenet’, I’m excited to collaborate with committed colleagues to strengthen the focus on diagnostics in Denmark. Our mission is clear: to make the value of diagnostics visible and to ensure it becomes a truly integrated and prioritized part of healthcare, from policy to practice.

At Fierce Pharma Week, leaders from the healthcare and life sciences industries came together to examine what it takes for pharma, health systems, and health tech to move from parallel efforts to true partnership.  The discussion surfaced both the friction and the promise of collaboration: health systems wary of brand-first approaches, pharma challenged by variability and complexity, and technology gaps that often stall progress.  Against that backdrop, the panel highlighted a coordinated program for high-risk respiratory patients that reached over 16,000 target patients across 11 systems.  ✅ Patients were contacted in the trusted voice of their provider  ✅ Clinicians received timely information at the point of care  ✅ Treatment decisions aligned with evidence-based guidelines  The result was measurable change and proof that when shared goals guide the work, collaboration stops being an experiment and becomes the new standard. Learn more at: https://lnkd.in/eM_Sh93D

The Impact of MDR and IVDR on European Healthcare Systems On October 20, experts will come together to shed light on one of the most pressing topics in healthcare regulation today: the development and execution of EU health legislation, and particularly the real-world consequences of the Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) for healthcare providers. ✅ They will address: - The current state of medical devices across Europe - Regulatory hurdles and bottlenecks in compliance - Emerging challenges and critical topics shaping the sector 📌 Why this matters: The transition to MDR/IVDR has proven complex, with ripple effects on supply chains, innovation, patient access, and cost structures. Meet at #BEHEALTH2025: 🔹 Basak Baranoglu Demirci – Founder, AdviQual 🔹 Ruth Beckers – QA/RA consultant medical devices, Qualix Belgium  🔹 Liz Renzaglia – Domain Lead – Medtech & Digital Health, Biovia  🔹 Flaviana Rotaru – President, ROHEALTH - The Health and Bioeconomy Cluster 🔹 Yves Verboven – Founder, EU4HS -Unlocking the Value of Innovation Moderator: Madalina A. – Senior Expert, ROHEALTH - The Health and Bioeconomy Cluster 👉 Join the event and discover the full potential of the ROHEALTH community. 📝 REGISTER NOW: https://lnkd.in/dWy9EWBp #BEHEALTH2025 is co-funded by the European Union through the #EU4Health programme. #EU4Health #BEHEALTH2025 #ROHEALTH #Healthcare #Bioeconomy #Cluster #Innovation #Research #HealthInnovation #FutureOfHealth #HealthTech #OneHealth #HealthEvent